carvedilol has been researched along with Mitral Valve Insufficiency in 14 studies
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We and others have previously shown that carvedilol improves left ventricular (LV) function and symptoms in chronic heart failure." | 9.09 | Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. ( Abraham, WT; Bristow, MR; Gilbert, EM; Gill, EA; Larrain, JR; Lowes, BD; Robertson, AD, 1999) |
| "In patients with chronic heart failure, the use of carvedilol therapy induces clinical and hemodynamic improvement." | 9.09 | Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. ( Capomolla, S; Caporotondi, A; Cobelli, F; Febo, O; Gnemmi, M; Mortara, A; Opasich, C; Pinna, GD; Riccardi, G, 2000) |
| "We and others have previously shown that carvedilol improves left ventricular (LV) function and symptoms in chronic heart failure." | 5.09 | Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. ( Abraham, WT; Bristow, MR; Gilbert, EM; Gill, EA; Larrain, JR; Lowes, BD; Robertson, AD, 1999) |
| "In patients with chronic heart failure, the use of carvedilol therapy induces clinical and hemodynamic improvement." | 5.09 | Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. ( Capomolla, S; Caporotondi, A; Cobelli, F; Febo, O; Gnemmi, M; Mortara, A; Opasich, C; Pinna, GD; Riccardi, G, 2000) |
| " Demographic, physical examination and diagnostic imaging findings, blood pressure (BP), administration details and outcome were obtained from medical records of dogs receiving carvedilol for preclinical CVD." | 3.78 | Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease. ( Boggess, MM; Gordon, SG; Hariu, CD; Miller, MW; Saunders, AB, 2012) |
| "Carvedilol was started in week 2 post MR induction and given for 23 to 35 weeks in the β-blockade group." | 1.39 | Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation. ( Davidson, WR; Gao, Z; Pu, DK; Pu, M, 2013) |
| "Recently described Takotsubo syndrome is characterized by acute reversible left ventricular dysfunction with apical ballooning in the absence of coronary artery disease, and with chest pain and electrocardiographic changes mimicking acute anterior myocardial infarction, but with minimal release of myocardial enzymes." | 1.35 | Takotsubo syndrome after cardiac surgery. ( Ghosh, P; Kogan, A; Raanani, E; Schwammenthal, E, 2008) |
| " Thus, it is necessary to titrate the dosage of carvedilol, it should be initiated at less than 0." | 1.31 | Cardiovascular and renal effects of carvedilol in dogs with heart failure. ( Ishikawa, Y; Sasaki, T; Uechi, M; Ueno, K; Yamamoto, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| McCutcheon, K | 1 |
| Dickens, C | 1 |
| van Pelt, J | 1 |
| Dix-Peek, T | 1 |
| Grinter, S | 1 |
| McCutcheon, L | 1 |
| Patel, A | 1 |
| Hale, M | 1 |
| Tsabedze, N | 1 |
| Vachiat, A | 1 |
| Zachariah, D | 1 |
| Duarte, R | 1 |
| Janssens, S | 1 |
| Manga, P | 1 |
| Tanaka, S | 1 |
| Imamura, T | 1 |
| Ueno, H | 1 |
| Kinugawa, K | 1 |
| Pu, M | 1 |
| Gao, Z | 1 |
| Pu, DK | 1 |
| Davidson, WR | 1 |
| Borer, JS | 1 |
| Marcondes-Santos, M | 1 |
| Mansur, AP | 1 |
| Fragata, FS | 1 |
| Strunz, CM | 1 |
| Gordon, SG | 1 |
| Saunders, AB | 1 |
| Hariu, CD | 1 |
| Boggess, MM | 1 |
| Miller, MW | 1 |
| Uechi, M | 1 |
| Sasaki, T | 1 |
| Ueno, K | 1 |
| Yamamoto, T | 1 |
| Ishikawa, Y | 1 |
| Kotlyar, E | 1 |
| Hayward, CS | 1 |
| Keogh, AM | 1 |
| Feneley, M | 1 |
| Macdonald, PS | 1 |
| Kogan, A | 1 |
| Ghosh, P | 1 |
| Schwammenthal, E | 1 |
| Raanani, E | 1 |
| Lowes, BD | 1 |
| Gill, EA | 1 |
| Abraham, WT | 1 |
| Larrain, JR | 1 |
| Robertson, AD | 1 |
| Bristow, MR | 1 |
| Gilbert, EM | 1 |
| Eichhorn, EJ | 1 |
| Grayburn, PA | 1 |
| Capomolla, S | 1 |
| Febo, O | 1 |
| Gnemmi, M | 1 |
| Riccardi, G | 1 |
| Opasich, C | 1 |
| Caporotondi, A | 1 |
| Mortara, A | 1 |
| Pinna, GD | 1 |
| Cobelli, F | 1 |
| Comin-Colet, J | 1 |
| Sánchez-Corral, MA | 1 |
| Manito, N | 1 |
| Gómez-Hospital, JA | 1 |
| Roca, J | 1 |
| Fernández-Nofrerias, E | 1 |
| Valdovinos, P | 1 |
| Esplugas, E | 1 |
| Nägele, H | 1 |
| Schomburg, R | 1 |
| Petersen, B | 1 |
| Rödiger, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Beta-Blockade in Chronic Mitral Regurgitation: Moving From the Laboratory Experiment to Clinical Investigation[NCT00700947] | Phase 1 | 27 participants (Actual) | Interventional | 2007-10-31 | Terminated (stopped due to Funding terminated) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for carvedilol and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Dynamic Changes in the Molecular Signature of Adverse Left Ventricular Remodeling in Patients With Compensated and Decompensated Chronic Primary Mitral Regurgitation.
Topics: Adult; Cardiovascular Agents; Carvedilol; Chronic Disease; Gene Expression Profiling; Humans; Middle | 2019 |
Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Carvedilol; Dou | 1999 |
beta-blocker improvement in diastolic performance: the yin and yang of ventricular function changes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Carvedilol; Diastole; Female; Heart Failure; H | 2000 |
Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Carvedilol; Diastole; Echocardiography; Female | 2000 |
Effect of carvedilol therapy on functional mitral regurgitation, ventricular remodeling, and contractility in patients with heart failure due to left ventricular systolic dysfunction.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Female; Follow-Up Studies; Heart Failure; Heart | 2002 |
Dual chamber pacing in patients with severe heart failure on beta blocker and amiodarone treatment: preliminary results of a randomised study.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiac Pacing, Artific | 2002 |
8 other studies available for carvedilol and Mitral Valve Insufficiency
| Article | Year |
|---|---|
MitraClip or Ventricular Assist Device?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Resynchronization The | 2020 |
Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Chronic Disease; Echoc | 2013 |
Mitral regurgitation: has another magic bullet bitten the dust?
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Mitral Valve Insufficiency; Propanolam | 2013 |
Short-term follow-up of exercise training program and beta-blocker treatment on quality of life in dogs with naturally acquired chronic mitral valve disease.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Carbazoles; Carvedilol; Dogs; Echocardio | 2015 |
Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Carbazoles; Carvedilol; Chronic Disease; Dog Diseases; | 2012 |
Cardiovascular and renal effects of carvedilol in dogs with heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agoni | 2002 |
The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chronic Disease; Echoc | 2004 |
Takotsubo syndrome after cardiac surgery.
Topics: Bioprosthesis; Carbazoles; Cardiopulmonary Bypass; Carvedilol; Echocardiography, Transesophageal; El | 2008 |